Screener
Lexicon Pharmaceuticals LXRX Total costs & expenses
Total costs & expenses at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of sales | 39 | 33 | 147 | 63 |
| Research and development, including stock-based compensation of $1,384, $1,620, $2,753, and $3,194 respectively | 17,443 | 15,747 | 30,199 | 31,050 |
| Selling, general and administrative, including stock-based compensation of $1,952, $1,575, $3,661, and $3,044 respectively | 9,750 | 9,350 | 18,984 | 20,958 |
| Total operating expenses | 27,232 | 25,130 | 49,330 | 52,071 |
| (Loss) income from operations | (26,540) | 3,736 | (27,536) | (21,943) |
| Interest and other expense | (2,609) | (2,318) | (4,199) | (4,153) |
| Interest and other income | 1,723 | 1,834 | 3,266 | 4,053 |
| Loss on early extinguishment of debt | (4,349) | — | (4,349) | — |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's total costs & expenses?
- Lexicon Pharmaceuticals (LXRX) reported total costs & expenses of $27.23M in Q2 2026.
- How has Lexicon Pharmaceuticals's total costs & expenses changed year-over-year?
- Lexicon Pharmaceuticals's total costs & expenses increased by 8.4% year-over-year, from $25.13M to $27.23M.
- What is the long-term trend for Lexicon Pharmaceuticals's total costs & expenses?
- Over 4 years (2021 to 2025), Lexicon Pharmaceuticals's total costs & expenses has grown at a 3.1% compound annual growth rate (CAGR), from $87.39M to $98.71M.
- What does total costs & expenses mean?
- The aggregate of all operating and non-operating costs incurred during the period, including research and development, selling, general, and administrative expenses. Monitoring this total provides insight into the company's overall burn rate and operational efficiency.
Ask your AI about Lexicon Pharmaceuticals's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude